Lifevantage (LFVN) Expected to Announce Earnings on Wednesday

Key Points

• Q3 2026 earnings due May 6 after the close: Analysts expect $0.16 EPS and $47.77M revenue, and the company has set FY2026 guidance of $0.60–$0.80 EPS; a conference call is scheduled for 4:30 PM ET that day.
• Recent results and stock profile: In the prior quarter Lifevantage missed estimates (reported $0.15 EPS vs. $0.22 expected; $48.93M revenue vs. $54.4M expected); shares trade near $5.19 with a market cap of ~$66.5M and an annualized dividend yield of 3.5%.
• Insider buying and analyst stance: Director Judd Dayton purchased 18,097 shares (raising his stake ~35%), insiders own ~21.95% of the stock, and the consensus rating is a Moderate Buy with an average price target of $5.00.

Lifevantage (NASDAQ:LFVN - Get Free Report) is expected to post its Q3 2026 results after the market closes on Wednesday, May 6th. Analysts expect Lifevantage to post earnings of $0.16 per share and revenue of $47.7740 million for the quarter. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS. Individuals can find conference call details on the company's upcoming Q3 2026 earning report page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 4:30 PM ET.

Lifevantage (NASDAQ:LFVN - Get Free Report) last issued its earnings results on Wednesday, February 4th. The company reported $0.15 earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by ($0.07). Lifevantage had a net margin of 3.74% and a return on equity of 29.59%. The company had revenue of $48.93 million during the quarter, compared to analyst estimates of $54.40 million. On average, analysts expect Lifevantage to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Lifevantage Price Performance

Shares of Lifevantage stock opened at $5.19 on Wednesday. Lifevantage has a fifty-two week low of $3.90 and a fifty-two week high of $15.00. The firm has a market capitalization of $66.46 million, a P/E ratio of 8.65 and a beta of 0.36. The company's 50 day moving average price is $4.66 and its two-hundred day moving average price is $5.91.

Lifevantage Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were given a $0.045 dividend. The ex-dividend date was Monday, March 2nd. This represents a $0.18 dividend on an annualized basis and a yield of 3.5%. Lifevantage's dividend payout ratio (DPR) is currently 30.00%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Loop Capital set a $5.00 target price on shares of Lifevantage in a research report on Thursday, February 5th. Lake Street Capital restated a "buy" rating on shares of Lifevantage in a research report on Thursday, February 5th. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Lifevantage in a research note on Friday, March 27th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $5.00.

Insiders Place Their Bets

In other news, Director Judd Dayton bought 18,097 shares of the stock in a transaction that occurred on Friday, February 27th. The stock was acquired at an average price of $4.63 per share, with a total value of $83,789.11. Following the completion of the purchase, the director directly owned 69,859 shares of the company's stock, valued at approximately $323,447.17. This represents a 34.96% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Insiders have acquired a total of 38,207 shares of company stock worth $178,585 over the last ninety days. 21.95% of the stock is owned by company insiders.

Hedge Funds Weigh In On Lifevantage

A number of hedge funds have recently bought and sold shares of LFVN. JPMorgan Chase & Co. increased its stake in Lifevantage by 870.2% in the second quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company's stock valued at $66,000 after purchasing an additional 4,499 shares in the last quarter. Franklin Resources Inc. acquired a new position in shares of Lifevantage during the fourth quarter valued at about $74,000. Jain Global LLC purchased a new position in Lifevantage during the fourth quarter worth about $76,000. Aristides Capital LLC purchased a new position in Lifevantage during the fourth quarter worth about $76,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in Lifevantage during the second quarter worth about $76,000. Institutional investors own 35.32% of the company's stock.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company's flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.